Nirmatrelvir in combination with ritonavir is an antiviral treatment for mild-to-moderate coronavirus disease 2019 (Covid-19). The efficacy of this treatment in patients who are at standard risk for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback